IL1B and uveitis: In the current era of pharmacotherapy for uveitis, we can theoretically target TNF, IL-1, IL-12/IL-23, IL-6, IL-17, CTLA4, CD20, etc.—various cytokines that have been identified in the serum and eyes of patients with different types of uveitis.